The molecular docking calculations have been employed to investigate the interactions a set of proteins with the repurposed anti-COVID drugs. The position of the therapeutic agents within the protein structure was dependent on a particular drug-protein system and varied from the binding cleft to the periphery of the polypeptide chain. Interactions involved in the drug-protein complexation includes predominantly hydrogen bonding and hydrophobic contacts. The obtained results may be of particular importance while developing the anti-COVID strategies as well as for deeper understanding of the drug pharmacodynamics and pharmacokinetics.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jpba.2023.115448 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Advancements in Antiviral Therapy: Favipiravir Sodium in Nasal Formulation.
AAPS PharmSciTech
November 2024
Innovation and Drug Discovery Division, Sava Healthcare Limited, Research Center, Block D1, Plot No. 17/6, MIDC, Chinchwad, Pune-411019, India.
Favipiravir (FPV) is an Active Pharmaceutical Ingredient (API) known to have lower solubility in aqueous solvents. In the current study, efforts were made to generate a crystalline Favipiravir Sodium Salt (NaFPV) for enhanced solubility in aqueous media. The in-house generated NaFPV was characterized by NMR studies and its sodium content was determined by Flame Emission Spectroscopy (FES) as a confirmation of salt formation.
View Article and Find Full Text PDFPotential of traditional medicines in alleviating COVID-19 symptoms.
Front Pharmacol
September 2024
School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.
Article Synopsis
- The review focuses on prevention and treatment strategies for COVID-19, highlighting the role of SARS-CoV-2 mutations in creating variants that evade immunity and some antiviral resistance.
- It identifies 150 natural metabolites and botanical drug-derived bioactive molecules that may offer more effective and less toxic alternatives for COVID-19 treatment, including Thai and Chinese traditional medicine approvals.
- The text emphasizes the impact of long COVID on about 10% of patients and suggests that botanical adjuvants, including vitamin C and E, might help alleviate symptoms and reduce the risk of long COVID progression.
Glucocorticoid treatment during COVID-19 infection: does it affect the incidence of long COVID?
Inflammopharmacology
December 2024
Department of Neurology, Carmel Medical Center, Mikhal St 7, 3436212, Haifa, Israel.
Background: Long COVID (LC) is a frequent complication of COVID infection. It usually results in cognitive impairment, myalgia, headache and fatigue. No effective treatment has been found yet.
View Article and Find Full Text PDFA potential allosteric inhibitor of SARS-CoV-2 main protease (M) identified through metastable state analysis.
Front Mol Biosci
September 2024
Division of Biological and Biomedical Sciences, College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar.
Anti-COVID19 drugs, such as nirmatrelvir, have been developed targeting the SARS-CoV-2 main protease, M, based on the critical requirement of its proteolytic processing of the viral polyproteins into functional proteins essential for viral replication. However, the emergence of SARS-CoV-2 variants with M mutations has raised the possibility of developing resistance against these drugs, likely due to therapeutic targeting of the M catalytic site. An alternative to these drugs is the development of drugs that target an allosteric site distant from the catalytic site in the protein that may reduce the chance of the emergence of resistant mutants.
View Article and Find Full Text PDFCOVID 19: Prevention and treatment through the Indian perspective.
Cytokine
November 2024
Department of Pharmacology, Faculty of Health Science, University of Free State, Bloemfontein 9300, South Africa. Electronic address:
The most destructive period the world has experienced seems to be behind us. Not a single nation was spared by this disease, and many continue to struggle today. Even after recovering from COVID, patient may continue to experience some post-COVID effects, such as heart irregularities or a decline in lung vitality.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!